16.07.2014 Views

Philips Sonicare FlexCare - Sonicare.com - Sonicare

Philips Sonicare FlexCare - Sonicare.com - Sonicare

Philips Sonicare FlexCare - Sonicare.com - Sonicare

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Table 1—Sample demographics (N = 87)<br />

Age (years)<br />

Mean ± SD 38.2 ± 11.57<br />

Median 38<br />

Range 19–64<br />

Sex<br />

Women 61 (70.1%)<br />

Men 26 (29.9%)<br />

Hand typically used for brushing<br />

Both 2 (2.3%)<br />

Left 5 (5.7%)<br />

Right 80 (92.0%)<br />

Number of teeth per subject<br />

Mean ± SD 27.2 ± 1.39<br />

Median 28<br />

Range 24–28<br />

TMQH plaque score (visit 1)<br />

Mean ± SD 3.10 ± 0.53<br />

Median 3.17<br />

Range 1.86–4.37<br />

SD = standard deviation; TMQH = Turesky Modified Quigley-<br />

Hein plaque index.<br />

ed. Each subject received a tube of Crest Cool Mint<br />

Gel toothpaste. b No other oral hygiene measures were<br />

permitted during the study. Subjects were requested<br />

to brush at home twice per day for 2 minutes using<br />

the materials provided. They received brushing<br />

instructions and a diary to record <strong>com</strong>pliance with an<br />

explanation on its use. To conclude the instruction<br />

session, subjects demonstrated their understanding<br />

of the directions by brushing with their assigned<br />

device in the presence of the instructor.<br />

Subjects used the device for a 6-day familiarization<br />

phase. They then refrained from brushing for<br />

24 ± 3 hours before returning to the clinic for the<br />

examinations and supervised 2-minute test brushing<br />

listed in Figure 1. All toothbrushes were supplied<br />

with new brush heads before the brushing episodes.<br />

Study End Points. The primary efficacy measure<br />

was percent plaque reduction. Using the TMQH, 19<br />

b<br />

Procter & Gamble Co; Cincinnati, OH.<br />

per-subject average scores were <strong>com</strong>puted and percent<br />

reduction was calculated per subject.<br />

Clinical Assessment. On presentation to the<br />

clinic at visits 2 and 3 (Figure 1), each subject<br />

received an intraoral examination, followed by a fullmouth<br />

plaque assessment using the TMQH. Plaque<br />

was disclosed and recorded at 6 sites per tooth on a<br />

scale of 0 to 5 to determine the prebrushing score.<br />

This procedure was repeated after the supervised 2-<br />

minute efficacy brushing and resulted in the postbrushing<br />

scores. All clinical assessments were made<br />

by the same calibrated examiner who was blinded to<br />

the treatment assignments. Reliability tests based on<br />

repeated grading of plaque scores were undertaken<br />

before the study and resulted in an excellent agreement<br />

(κ >0.75).<br />

Safety Assessment. Safety parameters included<br />

any adverse changes in the medical or dental status<br />

of the subject. The integrity of the oral mucosa was<br />

verified at the oral soft tissue examinations.<br />

Statistical Analysis. The study was designed to<br />

<strong>com</strong>pare the efficacy of 2 powered toothbrushes in<br />

removing plaque. The sample size was estimated based<br />

on data available from pilot studies. For a crossover<br />

design, a minimal difference between the treatment<br />

groups of 4%, an assumed within-subject standard<br />

deviation of 12%, and a 2-sided α = 0.05 level, a sample<br />

size of 80 subjects provided at least 80% power to<br />

detect a difference between treatment groups.<br />

The primary analysis was carried out on an<br />

intention-to-treat (ITT) basis. To qualify for inclusion,<br />

subjects were required to participate at all<br />

examinations, have <strong>com</strong>plete pre- and postbrushing<br />

data, and <strong>com</strong>ply with study instructions. Subjects<br />

were grouped according to the randomized treatment<br />

assignment. No correction to nominal P values<br />

was made for secondary and supplementary efficacy<br />

end points. The statistics for continuous variables<br />

included number of subjects, mean, and standard<br />

deviation. For categorical variables, numbers and<br />

percentages of events were <strong>com</strong>puted.<br />

Mean overall plaque scores were treated as con-<br />

Table 2—Summary results for primary study end point (% reduction in TMQH scores; mean ± SD; N = 87)<br />

Parameter Elite 9000 <strong>FlexCare</strong> P Value*<br />

Overall 37.35 ± 13.97 40.57 ± 14.48 .0039<br />

Anterior region 42.40 ± 17.18 46.86 ± 18.21 .0013<br />

Posterior region 34.21 ± 13.74 36.73 ± 14.14 .0182<br />

Interproximal surfaces 33.29 ± 13.62 37.36 ± 14.46 .0003<br />

Posterior interproximal surfaces 30.52 ± 13.46 33.45 ± 14.11 .0082<br />

*P values obtained from ANOVA F tests based on a mixed effects model.<br />

TMQH = Turesky Modified Quigley-Hein plaque index; SD = standard deviation; ANOVA = analysis of variance.<br />

Vol. 28, No. 9 (Suppl 1) Compendium / September 2007<br />

25

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!